The Peptide Guide logoPeptide GuideTirzepatide

Tirzepatide

AppetiteWeight

Tirzepatide is a dual GIP and GLP-1 receptor agonist studied extensively for glycemic control, appetite signaling, and weight management.

What does it do?

  • Lowers appetite so meals feel like enough sooner
  • Cuts snacking and food noise

How does it work?

  • Activates both GIP and GLP-1 receptors
  • GLP-1 reduces hunger and slows digestion

What to expect?

  • Food noise drops and a normal plate starts to feel like enough
  • Snacking loses its pull and you forget about extra bites more easily

How it's typically administered

  • Sub-Q injectiononce weekly; commonly delivered with a pre-filled pen

How it's typically dosed

  • Most common dose2.5–15 mg
  • FrequencyOnce weekly
  • Cycle durationTitrated every 4 weeks